Inventor · disambiguated record
Tracy S. Mitchell
Also filed as: MITCHELL TRACY · MITCHELL TRACY S
18 granted patents·5 pending applications·239 citations·filing 2011–2023
95Inventor score
Files withBRISTOL MYERS SQUIBB CO17CAMPHAUSEN RAY2LIB THERAPEUTICS LLC2GOSSELIN MICHAEL L1LIB THERAPEUTICS INC1
Top patents by PatentIndex Score
23 records- 0197US8420098B2Fibronectin based scaffold domain proteins that bind to PCSK9CAMPHAUSEN RAY·Filed 2011·Granted Apr 16, 2013·86 cites·8 claims
- 0294US9540424B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 10, 2017·27 cites·19 claims
- 0394US9469676B2Fc fusion proteins comprising novel linkers or arrangementsCAMPHAUSEN RAY·Filed 2012·Granted Oct 18, 2016·19 cites·7 claims
- 0494US8969289B2Serum albumin binding moleculesGOSSELIN MICHAEL L·Filed 2011·Granted Mar 3, 2015·45 cites·33 claims
- 0593US10221438B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 5, 2019·12 cites·16 claims
- 0692US11434275B2Fast-off rate serum albumin binding fibronectin type III domainsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Sep 6, 2022·3 cites·18 claims
- 0792US9856309B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 2, 2018·10 cites·16 claims
- 0891US10947297B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 16, 2021·5 cites·19 claims
- 0991US10934572B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 2, 2021·4 cites·16 claims
- 1090US10442851B2Serum albumin-binding fibronectin type III domainsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 15, 2019·5 cites·12 claims
- 1190US9234027B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 12, 2016·10 cites·22 claims
- 1288US10214579B2Fc fusion proteins comprising novel linkers or arrangementsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 26, 2019·3 cites·9 claims
- 1387US10766946B2Fast-off rate serum albumin binding fibronectin type III domainsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 8, 2020·4 cites·11 claims
- 1486US11203630B2Serum albumin-binding fibronectin type III domainsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 21, 2021·2 cites·9 claims
- 1586US2024239870A1Fibronectin based scaffold domain proteins that bind pcsk9BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1679US10738102B2Compositions comprising PCSK9-binding molecules and methods of useLIB THERAPEUTICS LLC·Filed 2019·Granted Aug 11, 2020·3 cites·30 claims
- 1778US11692021B2Compositions comprising PCSK9-binding molecules and methods of useLIB THERAPEUTICS LLC·Filed 2020·Granted Jul 4, 2023·1 cites·17 claims
- 1876US11858979B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jan 2, 2024·0 cites·10 claims
- 1972US2023145413A1Fast-off rate serum albumin binding fibronectin type iii domainsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2072US2021122805A1Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTSBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2171US12410236B2Compositions comprising PCSK9-binding molecules and methods of useLIB THERAPEUTICS INC·Filed 2023·Granted Sep 9, 2025·0 cites·8 claims
- 2270US2019248872A1Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTSBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2348US2016152686A1Fibronectin based scaffold domains linked to serum albumin or moiety binding theretoBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →